カテゴリー： Market Monitor Global, 世界, 医療/バイオ

ガレクチン阻害剤治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Galectin Inhibitor Therapeutics Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5575）

◆商品コード：MMG23JU5575
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月（※2025年版があります。お問い合わせください。）
◆ページ数：79
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Galectin Inhibitor Therapeutics Market 調査レポートは次の情報を含め、グローバルにおけるのガレクチン阻害剤治療薬市場規模と予測を収録しています。・世界のガレクチン阻害剤治療薬市場：売上、2018年-2023年、2024年-2029年
・世界のガレクチン阻害剤治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のガレクチン阻害剤治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「天然」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

ガレクチン阻害剤治療薬のグローバル主要企業は、GlycoMimetics (US)、 Galectin Therapeutics Inc (US)、 G3 Pharmaceuticals (India)、 iTeos (US)、 MandalMed, Inc (US)、 Angion (US)、 Novartis AG (Switzerland)、 Galecto Biotech (Denmark)、 Pfizer Inc. (US)、 Lilly (US)などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、ガレクチン阻害剤治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のガレクチン阻害剤治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界のガレクチン阻害剤治療薬市場：タイプ別市場シェア、2022年
・天然、合成

世界のガレクチン阻害剤治療薬市場：用途別、2018年-2023年、2024年-2029年
世界のガレクチン阻害剤治療薬市場：用途別市場シェア、2022年
・糖尿病、心不全、喘息、関節リウマチ、その他

世界のガレクチン阻害剤治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界のガレクチン阻害剤治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるガレクチン阻害剤治療薬のグローバル売上、2018年-2023年
・主要企業におけるガレクチン阻害剤治療薬のグローバル売上シェア、2022年
・主要企業におけるガレクチン阻害剤治療薬のグローバル販売量、2018年-2023年
・主要企業におけるガレクチン阻害剤治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
GlycoMimetics (US)、 Galectin Therapeutics Inc (US)、 G3 Pharmaceuticals (India)、 iTeos (US)、 MandalMed, Inc (US)、 Angion (US)、 Novartis AG (Switzerland)、 Galecto Biotech (Denmark)、 Pfizer Inc. (US)、 Lilly (US)

*************************************************************

・調査・分析レポートの概要
ガレクチン阻害剤治療薬市場の定義
市場セグメント
世界のガレクチン阻害剤治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のガレクチン阻害剤治療薬市場規模
世界のガレクチン阻害剤治療薬市場規模：2022年 VS 2029年
世界のガレクチン阻害剤治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのガレクチン阻害剤治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のガレクチン阻害剤治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：天然、合成
ガレクチン阻害剤治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：糖尿病、心不全、喘息、関節リウマチ、その他
ガレクチン阻害剤治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別ガレクチン阻害剤治療薬市場規模 2022年と2029年
地域別ガレクチン阻害剤治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
GlycoMimetics (US)、 Galectin Therapeutics Inc (US)、 G3 Pharmaceuticals (India)、 iTeos (US)、 MandalMed, Inc (US)、 Angion (US)、 Novartis AG (Switzerland)、 Galecto Biotech (Denmark)、 Pfizer Inc. (US)、 Lilly (US)
...

This report aims to provide a comprehensive presentation of the global market for Galectin Inhibitor Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Galectin Inhibitor Therapeutics. This report contains market size and forecasts of Galectin Inhibitor Therapeutics in global, including the following market information:
Global Galectin Inhibitor Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Galectin Inhibitor Therapeutics Market Sales, 2018-2023, 2024-2029, (Kiloton)
Global top five Galectin Inhibitor Therapeutics companies in 2022 (%)
The global Galectin Inhibitor Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Natural Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Galectin Inhibitor Therapeutics include GlycoMimetics (US), Galectin Therapeutics Inc (US), G3 Pharmaceuticals (India), iTeos (US), MandalMed, Inc (US), Angion (US), Novartis AG (Switzerland), Galecto Biotech (Denmark) and Pfizer Inc. (US), etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Galectin Inhibitor Therapeutics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Galectin Inhibitor Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Kiloton)
Global Galectin Inhibitor Therapeutics Market Segment Percentages, by Type, 2022 (%)
Natural
Synthetic
Global Galectin Inhibitor Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Kiloton)
Global Galectin Inhibitor Therapeutics Market Segment Percentages, by Application, 2022 (%)
Diabetes
Heart Failure
Asthma
Rheumatoid Arthritis
Other
Global Galectin Inhibitor Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Kiloton)
Global Galectin Inhibitor Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Galectin Inhibitor Therapeutics revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Galectin Inhibitor Therapeutics revenues share in global market, 2022 (%)
Key companies Galectin Inhibitor Therapeutics sales in global market, 2018-2023 (Estimated), (Kiloton)
Key companies Galectin Inhibitor Therapeutics sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlycoMimetics (US)
Galectin Therapeutics Inc (US)
G3 Pharmaceuticals (India)
iTeos (US)
MandalMed, Inc (US)
Angion (US)
Novartis AG (Switzerland)
Galecto Biotech (Denmark)
Pfizer Inc. (US)
Lilly (US)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Galectin Inhibitor Therapeutics, market overview.
Chapter 2: Global Galectin Inhibitor Therapeutics market size in revenue and volume.
Chapter 3: Detailed analysis of Galectin Inhibitor Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Galectin Inhibitor Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Galectin Inhibitor Therapeutics capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Galectin Inhibitor Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Galectin Inhibitor Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Galectin Inhibitor Therapeutics Overall Market Size
2.1 Global Galectin Inhibitor Therapeutics Market Size: 2022 VS 2029
2.2 Global Galectin Inhibitor Therapeutics Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Galectin Inhibitor Therapeutics Sales: 2018-2029
3 Company Landscape
3.1 Top Galectin Inhibitor Therapeutics Players in Global Market
3.2 Top Global Galectin Inhibitor Therapeutics Companies Ranked by Revenue
3.3 Global Galectin Inhibitor Therapeutics Revenue by Companies
3.4 Global Galectin Inhibitor Therapeutics Sales by Companies
3.5 Global Galectin Inhibitor Therapeutics Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Galectin Inhibitor Therapeutics Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Galectin Inhibitor Therapeutics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Galectin Inhibitor Therapeutics Players in Global Market
3.8.1 List of Global Tier 1 Galectin Inhibitor Therapeutics Companies
3.8.2 List of Global Tier 2 and Tier 3 Galectin Inhibitor Therapeutics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Galectin Inhibitor Therapeutics Market Size Markets, 2022 & 2029
4.1.2 Natural
4.1.3 Synthetic
4.2 By Type – Global Galectin Inhibitor Therapeutics Revenue & Forecasts
4.2.1 By Type – Global Galectin Inhibitor Therapeutics Revenue, 2018-2023
4.2.2 By Type – Global Galectin Inhibitor Therapeutics Revenue, 2024-2029
4.2.3 By Type – Global Galectin Inhibitor Therapeutics Revenue Market Share, 2018-2029
4.3 By Type – Global Galectin Inhibitor Therapeutics Sales & Forecasts
4.3.1 By Type – Global Galectin Inhibitor Therapeutics Sales, 2018-2023
4.3.2 By Type – Global Galectin Inhibitor Therapeutics Sales, 2024-2029
4.3.3 By Type – Global Galectin Inhibitor Therapeutics Sales Market Share, 2018-2029
4.4 By Type – Global Galectin Inhibitor Therapeutics Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Galectin Inhibitor Therapeutics Market Size, 2022 & 2029
5.1.2 Diabetes
5.1.3 Heart Failure
5.1.4 Asthma
5.1.5 Rheumatoid Arthritis
5.1.6 Other
5.2 By Application – Global Galectin Inhibitor Therapeutics Revenue & Forecasts
5.2.1 By Application – Global Galectin Inhibitor Therapeutics Revenue, 2018-2023
5.2.2 By Application – Global Galectin Inhibitor Therapeutics Revenue, 2024-2029
5.2.3 By Application – Global Galectin Inhibitor Therapeutics Revenue Market Share, 2018-2029
5.3 By Application – Global Galectin Inhibitor Therapeutics Sales & Forecasts
5.3.1 By Application – Global Galectin Inhibitor Therapeutics Sales, 2018-2023
5.3.2 By Application – Global Galectin Inhibitor Therapeutics Sales, 2024-2029
5.3.3 By Application – Global Galectin Inhibitor Therapeutics Sales Market Share, 2018-2029
5.4 By Application – Global Galectin Inhibitor Therapeutics Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Galectin Inhibitor Therapeutics Market Size, 2022 & 2029
6.2 By Region – Global Galectin Inhibitor Therapeutics Revenue & Forecasts
6.2.1 By Region – Global Galectin Inhibitor Therapeutics Revenue, 2018-2023
6.2.2 By Region – Global Galectin Inhibitor Therapeutics Revenue, 2024-2029
6.2.3 By Region – Global Galectin Inhibitor Therapeutics Revenue Market Share, 2018-2029
6.3 By Region – Global Galectin Inhibitor Therapeutics Sales & Forecasts
6.3.1 By Region – Global Galectin Inhibitor Therapeutics Sales, 2018-2023
6.3.2 By Region – Global Galectin Inhibitor Therapeutics Sales, 2024-2029
6.3.3 By Region – Global Galectin Inhibitor Therapeutics Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Galectin Inhibitor Therapeutics Revenue, 2018-2029
6.4.2 By Country – North America Galectin Inhibitor Therapeutics Sales, 2018-2029
6.4.3 US Galectin Inhibitor Therapeutics Market Size, 2018-2029
6.4.4 Canada Galectin Inhibitor Therapeutics Market Size, 2018-2029
6.4.5 Mexico Galectin Inhibitor Therapeutics Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Galectin Inhibitor Therapeutics Revenue, 2018-2029
6.5.2 By Country – Europe Galectin Inhibitor Therapeutics Sales, 2018-2029
6.5.3 Germany Galectin Inhibitor Therapeutics Market Size, 2018-2029
6.5.4 France Galectin Inhibitor Therapeutics Market Size, 2018-2029
6.5.5 U.K. Galectin Inhibitor Therapeutics Market Size, 2018-2029
6.5.6 Italy Galectin Inhibitor Therapeutics Market Size, 2018-2029
6.5.7 Russia Galectin Inhibitor Therapeutics Market Size, 2018-2029
6.5.8 Nordic Countries Galectin Inhibitor Therapeutics Market Size, 2018-2029
6.5.9 Benelux Galectin Inhibitor Therapeutics Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Galectin Inhibitor Therapeutics Revenue, 2018-2029
6.6.2 By Region – Asia Galectin Inhibitor Therapeutics Sales, 2018-2029
6.6.3 China Galectin Inhibitor Therapeutics Market Size, 2018-2029
6.6.4 Japan Galectin Inhibitor Therapeutics Market Size, 2018-2029
6.6.5 South Korea Galectin Inhibitor Therapeutics Market Size, 2018-2029
6.6.6 Southeast Asia Galectin Inhibitor Therapeutics Market Size, 2018-2029
6.6.7 India Galectin Inhibitor Therapeutics Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Galectin Inhibitor Therapeutics Revenue, 2018-2029
6.7.2 By Country – South America Galectin Inhibitor Therapeutics Sales, 2018-2029
6.7.3 Brazil Galectin Inhibitor Therapeutics Market Size, 2018-2029
6.7.4 Argentina Galectin Inhibitor Therapeutics Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Galectin Inhibitor Therapeutics Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Galectin Inhibitor Therapeutics Sales, 2018-2029
6.8.3 Turkey Galectin Inhibitor Therapeutics Market Size, 2018-2029
6.8.4 Israel Galectin Inhibitor Therapeutics Market Size, 2018-2029
6.8.5 Saudi Arabia Galectin Inhibitor Therapeutics Market Size, 2018-2029
6.8.6 UAE Galectin Inhibitor Therapeutics Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GlycoMimetics (US)
7.1.1 GlycoMimetics (US) Company Summary
7.1.2 GlycoMimetics (US) Business Overview
7.1.3 GlycoMimetics (US) Galectin Inhibitor Therapeutics Major Product Offerings
7.1.4 GlycoMimetics (US) Galectin Inhibitor Therapeutics Sales and Revenue in Global (2018-2023)
7.1.5 GlycoMimetics (US) Key News & Latest Developments
7.2 Galectin Therapeutics Inc (US)
7.2.1 Galectin Therapeutics Inc (US) Company Summary
7.2.2 Galectin Therapeutics Inc (US) Business Overview
7.2.3 Galectin Therapeutics Inc (US) Galectin Inhibitor Therapeutics Major Product Offerings
7.2.4 Galectin Therapeutics Inc (US) Galectin Inhibitor Therapeutics Sales and Revenue in Global (2018-2023)
7.2.5 Galectin Therapeutics Inc (US) Key News & Latest Developments
7.3 G3 Pharmaceuticals (India)
7.3.1 G3 Pharmaceuticals (India) Company Summary
7.3.2 G3 Pharmaceuticals (India) Business Overview
7.3.3 G3 Pharmaceuticals (India) Galectin Inhibitor Therapeutics Major Product Offerings
7.3.4 G3 Pharmaceuticals (India) Galectin Inhibitor Therapeutics Sales and Revenue in Global (2018-2023)
7.3.5 G3 Pharmaceuticals (India) Key News & Latest Developments
7.4 iTeos (US)
7.4.1 iTeos (US) Company Summary
7.4.2 iTeos (US) Business Overview
7.4.3 iTeos (US) Galectin Inhibitor Therapeutics Major Product Offerings
7.4.4 iTeos (US) Galectin Inhibitor Therapeutics Sales and Revenue in Global (2018-2023)
7.4.5 iTeos (US) Key News & Latest Developments
7.5 MandalMed, Inc (US)
7.5.1 MandalMed, Inc (US) Company Summary
7.5.2 MandalMed, Inc (US) Business Overview
7.5.3 MandalMed, Inc (US) Galectin Inhibitor Therapeutics Major Product Offerings
7.5.4 MandalMed, Inc (US) Galectin Inhibitor Therapeutics Sales and Revenue in Global (2018-2023)
7.5.5 MandalMed, Inc (US) Key News & Latest Developments
7.6 Angion (US)
7.6.1 Angion (US) Company Summary
7.6.2 Angion (US) Business Overview
7.6.3 Angion (US) Galectin Inhibitor Therapeutics Major Product Offerings
7.6.4 Angion (US) Galectin Inhibitor Therapeutics Sales and Revenue in Global (2018-2023)
7.6.5 Angion (US) Key News & Latest Developments
7.7 Novartis AG (Switzerland)
7.7.1 Novartis AG (Switzerland) Company Summary
7.7.2 Novartis AG (Switzerland) Business Overview
7.7.3 Novartis AG (Switzerland) Galectin Inhibitor Therapeutics Major Product Offerings
7.7.4 Novartis AG (Switzerland) Galectin Inhibitor Therapeutics Sales and Revenue in Global (2018-2023)
7.7.5 Novartis AG (Switzerland) Key News & Latest Developments
7.8 Galecto Biotech (Denmark)
7.8.1 Galecto Biotech (Denmark) Company Summary
7.8.2 Galecto Biotech (Denmark) Business Overview
7.8.3 Galecto Biotech (Denmark) Galectin Inhibitor Therapeutics Major Product Offerings
7.8.4 Galecto Biotech (Denmark) Galectin Inhibitor Therapeutics Sales and Revenue in Global (2018-2023)
7.8.5 Galecto Biotech (Denmark) Key News & Latest Developments
7.9 Pfizer Inc. (US)
7.9.1 Pfizer Inc. (US) Company Summary
7.9.2 Pfizer Inc. (US) Business Overview
7.9.3 Pfizer Inc. (US) Galectin Inhibitor Therapeutics Major Product Offerings
7.9.4 Pfizer Inc. (US) Galectin Inhibitor Therapeutics Sales and Revenue in Global (2018-2023)
7.9.5 Pfizer Inc. (US) Key News & Latest Developments
7.10 Lilly (US)
7.10.1 Lilly (US) Company Summary
7.10.2 Lilly (US) Business Overview
7.10.3 Lilly (US) Galectin Inhibitor Therapeutics Major Product Offerings
7.10.4 Lilly (US) Galectin Inhibitor Therapeutics Sales and Revenue in Global (2018-2023)
7.10.5 Lilly (US) Key News & Latest Developments
8 Global Galectin Inhibitor Therapeutics Production Capacity, Analysis
8.1 Global Galectin Inhibitor Therapeutics Production Capacity, 2018-2029
8.2 Galectin Inhibitor Therapeutics Production Capacity of Key Manufacturers in Global Market
8.3 Global Galectin Inhibitor Therapeutics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Galectin Inhibitor Therapeutics Supply Chain Analysis
10.1 Galectin Inhibitor Therapeutics Industry Value Chain
10.2 Galectin Inhibitor Therapeutics Upstream Market
10.3 Galectin Inhibitor Therapeutics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Galectin Inhibitor Therapeutics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Galectin Inhibitor Therapeutics in Global Market
Table 2. Top Galectin Inhibitor Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Galectin Inhibitor Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Galectin Inhibitor Therapeutics Revenue Share by Companies, 2018-2023
Table 5. Global Galectin Inhibitor Therapeutics Sales by Companies, (Kiloton), 2018-2023
Table 6. Global Galectin Inhibitor Therapeutics Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Galectin Inhibitor Therapeutics Price (2018-2023) & (US$/Ton)
Table 8. Global Manufacturers Galectin Inhibitor Therapeutics Product Type
Table 9. List of Global Tier 1 Galectin Inhibitor Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Galectin Inhibitor Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Galectin Inhibitor Therapeutics Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Galectin Inhibitor Therapeutics Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Galectin Inhibitor Therapeutics Sales (Kiloton), 2018-2023
Table 15. By Type - Global Galectin Inhibitor Therapeutics Sales (Kiloton), 2024-2029
Table 16. By Application – Global Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Galectin Inhibitor Therapeutics Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Galectin Inhibitor Therapeutics Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Galectin Inhibitor Therapeutics Sales (Kiloton), 2018-2023
Table 20. By Application - Global Galectin Inhibitor Therapeutics Sales (Kiloton), 2024-2029
Table 21. By Region – Global Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Galectin Inhibitor Therapeutics Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Galectin Inhibitor Therapeutics Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Galectin Inhibitor Therapeutics Sales (Kiloton), 2018-2023
Table 25. By Region - Global Galectin Inhibitor Therapeutics Sales (Kiloton), 2024-2029
Table 26. By Country - North America Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Galectin Inhibitor Therapeutics Sales, (Kiloton), 2018-2023
Table 29. By Country - North America Galectin Inhibitor Therapeutics Sales, (Kiloton), 2024-2029
Table 30. By Country - Europe Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Galectin Inhibitor Therapeutics Sales, (Kiloton), 2018-2023
Table 33. By Country - Europe Galectin Inhibitor Therapeutics Sales, (Kiloton), 2024-2029
Table 34. By Region - Asia Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Galectin Inhibitor Therapeutics Sales, (Kiloton), 2018-2023
Table 37. By Region - Asia Galectin Inhibitor Therapeutics Sales, (Kiloton), 2024-2029
Table 38. By Country - South America Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Galectin Inhibitor Therapeutics Sales, (Kiloton), 2018-2023
Table 41. By Country - South America Galectin Inhibitor Therapeutics Sales, (Kiloton), 2024-2029
Table 42. By Country - Middle East & Africa Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Galectin Inhibitor Therapeutics Sales, (Kiloton), 2018-2023
Table 45. By Country - Middle East & Africa Galectin Inhibitor Therapeutics Sales, (Kiloton), 2024-2029
Table 46. GlycoMimetics (US) Company Summary
Table 47. GlycoMimetics (US) Galectin Inhibitor Therapeutics Product Offerings
Table 48. GlycoMimetics (US) Galectin Inhibitor Therapeutics Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 49. GlycoMimetics (US) Key News & Latest Developments
Table 50. Galectin Therapeutics Inc (US) Company Summary
Table 51. Galectin Therapeutics Inc (US) Galectin Inhibitor Therapeutics Product Offerings
Table 52. Galectin Therapeutics Inc (US) Galectin Inhibitor Therapeutics Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 53. Galectin Therapeutics Inc (US) Key News & Latest Developments
Table 54. G3 Pharmaceuticals (India) Company Summary
Table 55. G3 Pharmaceuticals (India) Galectin Inhibitor Therapeutics Product Offerings
Table 56. G3 Pharmaceuticals (India) Galectin Inhibitor Therapeutics Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 57. G3 Pharmaceuticals (India) Key News & Latest Developments
Table 58. iTeos (US) Company Summary
Table 59. iTeos (US) Galectin Inhibitor Therapeutics Product Offerings
Table 60. iTeos (US) Galectin Inhibitor Therapeutics Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 61. iTeos (US) Key News & Latest Developments
Table 62. MandalMed, Inc (US) Company Summary
Table 63. MandalMed, Inc (US) Galectin Inhibitor Therapeutics Product Offerings
Table 64. MandalMed, Inc (US) Galectin Inhibitor Therapeutics Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 65. MandalMed, Inc (US) Key News & Latest Developments
Table 66. Angion (US) Company Summary
Table 67. Angion (US) Galectin Inhibitor Therapeutics Product Offerings
Table 68. Angion (US) Galectin Inhibitor Therapeutics Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 69. Angion (US) Key News & Latest Developments
Table 70. Novartis AG (Switzerland) Company Summary
Table 71. Novartis AG (Switzerland) Galectin Inhibitor Therapeutics Product Offerings
Table 72. Novartis AG (Switzerland) Galectin Inhibitor Therapeutics Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 73. Novartis AG (Switzerland) Key News & Latest Developments
Table 74. Galecto Biotech (Denmark) Company Summary
Table 75. Galecto Biotech (Denmark) Galectin Inhibitor Therapeutics Product Offerings
Table 76. Galecto Biotech (Denmark) Galectin Inhibitor Therapeutics Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 77. Galecto Biotech (Denmark) Key News & Latest Developments
Table 78. Pfizer Inc. (US) Company Summary
Table 79. Pfizer Inc. (US) Galectin Inhibitor Therapeutics Product Offerings
Table 80. Pfizer Inc. (US) Galectin Inhibitor Therapeutics Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 81. Pfizer Inc. (US) Key News & Latest Developments
Table 82. Lilly (US) Company Summary
Table 83. Lilly (US) Galectin Inhibitor Therapeutics Product Offerings
Table 84. Lilly (US) Galectin Inhibitor Therapeutics Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 85. Lilly (US) Key News & Latest Developments
Table 86. Galectin Inhibitor Therapeutics Production Capacity (Kiloton) of Key Manufacturers in Global Market, 2021-2023 (Kiloton)
Table 87. Global Galectin Inhibitor Therapeutics Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Galectin Inhibitor Therapeutics Production by Region, 2018-2023 (Kiloton)
Table 89. Global Galectin Inhibitor Therapeutics Production by Region, 2024-2029 (Kiloton)
Table 90. Galectin Inhibitor Therapeutics Market Opportunities & Trends in Global Market
Table 91. Galectin Inhibitor Therapeutics Market Drivers in Global Market
Table 92. Galectin Inhibitor Therapeutics Market Restraints in Global Market
Table 93. Galectin Inhibitor Therapeutics Raw Materials
Table 94. Galectin Inhibitor Therapeutics Raw Materials Suppliers in Global Market
Table 95. Typical Galectin Inhibitor Therapeutics Downstream
Table 96. Galectin Inhibitor Therapeutics Downstream Clients in Global Market
Table 97. Galectin Inhibitor Therapeutics Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Galectin Inhibitor Therapeutics Segment by Type in 2022
Figure 2. Galectin Inhibitor Therapeutics Segment by Application in 2022
Figure 3. Global Galectin Inhibitor Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Galectin Inhibitor Therapeutics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Galectin Inhibitor Therapeutics Revenue, 2018-2029 (US$, Mn)
Figure 7. Galectin Inhibitor Therapeutics Sales in Global Market: 2018-2029 (Kiloton)
Figure 8. The Top 3 and 5 Players Market Share by Galectin Inhibitor Therapeutics Revenue in 2022
Figure 9. By Type - Global Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Galectin Inhibitor Therapeutics Revenue Market Share, 2018-2029
Figure 11. By Type - Global Galectin Inhibitor Therapeutics Sales Market Share, 2018-2029
Figure 12. By Type - Global Galectin Inhibitor Therapeutics Price (US$/Ton), 2018-2029
Figure 13. By Application - Global Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Galectin Inhibitor Therapeutics Revenue Market Share, 2018-2029
Figure 15. By Application - Global Galectin Inhibitor Therapeutics Sales Market Share, 2018-2029
Figure 16. By Application - Global Galectin Inhibitor Therapeutics Price (US$/Ton), 2018-2029
Figure 17. By Region - Global Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Galectin Inhibitor Therapeutics Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Galectin Inhibitor Therapeutics Revenue Market Share, 2018-2029
Figure 20. By Region - Global Galectin Inhibitor Therapeutics Sales Market Share, 2018-2029
Figure 21. By Country - North America Galectin Inhibitor Therapeutics Revenue Market Share, 2018-2029
Figure 22. By Country - North America Galectin Inhibitor Therapeutics Sales Market Share, 2018-2029
Figure 23. US Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Galectin Inhibitor Therapeutics Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Galectin Inhibitor Therapeutics Sales Market Share, 2018-2029
Figure 28. Germany Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 29. France Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Galectin Inhibitor Therapeutics Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Galectin Inhibitor Therapeutics Sales Market Share, 2018-2029
Figure 37. China Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 41. India Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Galectin Inhibitor Therapeutics Revenue Market Share, 2018-2029
Figure 43. By Country - South America Galectin Inhibitor Therapeutics Sales Market Share, 2018-2029
Figure 44. Brazil Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Galectin Inhibitor Therapeutics Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Galectin Inhibitor Therapeutics Sales Market Share, 2018-2029
Figure 48. Turkey Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Galectin Inhibitor Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 52. Global Galectin Inhibitor Therapeutics Production Capacity (Kiloton), 2018-2029
Figure 53. The Percentage of Production Galectin Inhibitor Therapeutics by Region, 2022 VS 2029
Figure 54. Galectin Inhibitor Therapeutics Industry Value Chain
Figure 55. Marketing Channels

※参考情報

ガレクチン阻害剤治療薬は、ガレクチンという特定のタンパク質に作用することで、さまざまな疾患の治療を目指す新しいタイプの薬剤です。ガレクチンは糖鎖に結合することで細胞間の相互作用やシグナル伝達に関与しており、特にがん、自己免疫疾患、炎症性疾患などの病態において重要な役割を果たしています。このような背景から、ガレクチンを標的とした治療戦略が注目されています。

まず、ガレクチンの定義について説明しましょう。ガレクチンは、糖鎖を認識し結合する能力を持つタンパク質群であり、現在までに多くの種類が知られています。ヒトにおいては、少なくとも15種類のガレクチンが同定されており、それぞれ異なる機能や細胞タイプにおける発現パターンを持っています。ガレクチンは、免疫応答の調節、細胞の増殖や分化、組織の修復など、さまざまな生理学的プロセスに関与しており、その異常な活性は病気の進行に寄与することが知られています。

ガレクチン阻害剤の特徴には、主にその選択性と効果の多様性があります。ガレクチン阻害剤は、特定のガレクチンの機能を阻害することによって、病態の進行を遅らせる、あるいは逆転させる作用を持ちます。例えば、がん細胞はしばしばガレクチンの過剰発現を示し、これが腫瘍の浸潤や転移を促進するとされています。したがって、ガレクチンを抑制することは、がん治療において非常に有効な戦略となり得ます。

次に、ガレクチン阻害剤の種類について触れます。ガレクチン阻害剤には、選択的な小分子化合物のほか、抗体療法やRNA干渉技術を用いたものなど、多様なアプローチがあります。小分子ガレクチン阻害剤は、特に開発が進んでおり、これまでの研究からいくつかの候補化合物が臨床試験段階に進んでいます。これらの化合物は、特定のガレクチンに対して高い選択性を持ち、他のタンパク質に対する副作用を最小限に抑えることが期待されています。

ガレクチン阻害剤の用途は非常に広範であり、主にがん治療、自己免疫疾患、炎症、線維症などの領域での適用が研究されています。がん治療においては、特に腫瘍微環境の調節に寄与するガレクチンの役割が注目されており、これに対抗するための新たな治療法としての位置づけが進んでいます。また、自己免疫疾患や炎症性疾患においても、免疫系の異常な活性を抑制するためにガレクチン阻害剤が有望視されています。

関連技術としては、バイオマーカーの発見や、ガレクチンの作用メカニズムの解明が挙げられます。例えば、がん患者の血液中のガレクチン濃度を測定することで、治療効果の指標として利用できる可能性があります。また、ガレクチンの相互作用を可視化する技術の開発も進んでおり、これにより新たな標的の同定や治療の最適化が期待されています。

活用の面では、ガレクチン阻害剤は単剤療法としてだけでなく、他の治療法との併用も検討されています。特に免疫療法や化学療法との併用が研究されており、ガレクチンの阻害がこれらの治療の効果をどのように高めるか、という観点から多くの臨床的研究が進行中です。これらの研究によって、ガレクチン阻害剤が持つ治療ポテンシャルがより具体化し、実用化への道が開かれることでしょう。

ガレクチン阻害剤の研究はまだ始まったばかりであり、多くの課題も存在します。例えば、長期的な安全性や副作用の観点からの詳細なリスク評価が必要です。また、ガレクチンの異なるアイソフォームや各種の細胞環境における役割の違いを理解することも重要であり、これらの知見が新たな治療戦略の開発に繋がると考えられます。

総じて、ガレクチン阻害剤治療薬は、革新的な治療法として期待されており、さまざまな病気の治療における新たな選択肢を提供する可能性を秘めています。今後の研究および臨床試験の進展が、ガレクチン阻害剤の有効性を証明し、治療現場での活用が進むことを期待しています。ガレクチン阻害剤は、既存の治療法と組み合わせることによって、より良い治療効果を達成できる可能性があり、未来の医療において重要な役割を果たすと考えられます。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ガレクチン阻害剤治療薬の世界市場見通し2023年-2029年(Galectin Inhibitor Therapeutics Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

ガレクチン阻害剤治療薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp